Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

79
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
79
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

42
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
42
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

116
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
116
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

688
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
688
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

400
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
400
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

428
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
428

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis.

Surgical endoscopy·2018
Same author

Genetic diversity of <i>Cahi DRB</i> and <i>DQB</i> genes of caprine MHC class II in Sirohi goat.

Journal of genetics·2018
Same author

Observation of tt[over ¯]H Production.

Physical review letters·2018
Same author

Adult Influenza A (H1N1) Related Encephalitis: A Case Report.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2018
Same author

Search for Heavy Neutral Leptons in Events with Three Charged Leptons in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2018
Same author

Search for the X(5568) State Decaying into B_{s}^{0}π^{±} in Proton-Proton Collisions at sqrt[s]=8  TeV.

Physical review letters·2018

Related Experiment Video

Updated: Oct 14, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.4K

MIS-C is a Clinically Different Entity from Acute COVID-19 in Adults.

Bharat Mehra1, Vyom Aggarwal2, Praveen Kumar3

  • 1Department of Pediatric Intensive Care, Max Super Speciality Hospital, Shalimar Bagh, Delhi, India.

Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|November 4, 2021
PubMed
Summary

Multisystem Inflammatory Syndrome in Children (MIS-C) presents differently in adults compared to acute COVID-19. This study highlights MIS-C as a distinct clinical condition requiring specific diagnostic considerations.

Keywords:
Acute disseminated encephalomyelitis (ADEM)Guillain Barre SyndromeMultisystem inflammatory syndrome children (MIS-C)

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.7K

Related Experiment Videos

Last Updated: Oct 14, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.4K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.7K

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Immunology

Background:

  • The COVID-19 pandemic has led to the emergence of Multisystem Inflammatory Syndrome in Children (MIS-C).
  • While MIS-C is recognized in pediatric populations, its manifestation in adults requires further elucidation.
  • Distinguishing MIS-C from acute COVID-19 in adults is crucial for appropriate management.

Purpose of the Study:

  • To delineate the clinical characteristics of MIS-C in adult patients.
  • To compare the clinical presentation of MIS-C with acute COVID-19 in adults.
  • To establish MIS-C as a distinct clinical entity in the adult population.

Main Methods:

  • Retrospective analysis of adult patients diagnosed with MIS-C.
  • Comparison of clinical data, laboratory findings, and treatment outcomes between MIS-C and acute COVID-19 adult cohorts.
  • Review of diagnostic criteria and clinical manifestations.

Main Results:

  • Adult MIS-C cases exhibited distinct clinical features compared to acute COVID-19.
  • Key differences were observed in organ system involvement and inflammatory markers.
  • The study identified specific patterns differentiating MIS-C from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Conclusions:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) represents a clinically unique condition in adults, separate from acute COVID-19.
  • Recognizing these differences is essential for accurate diagnosis and targeted therapeutic strategies in adult patients.
  • Further research is warranted to fully understand the pathophysiology and long-term implications of MIS-C in adults.